A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SMNs / second malignant neoplasms

[Related PubMed/MEDLINE]
Total Number of Papers: 86
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SMNs  (>> Co-occurring Abbreviation)
Long Form:   second malignant neoplasms
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma. IMRT, OARs
2021 Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue. HDC, HR-NB
2021 Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis. CIs, CNS, O/E, RT
2021 Stage I testicular seminoma risk-adapted therapeutic management. ACT, ART, CSI, PFS
2021 The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database. AER, DLBCL, SEER, SIR
2020 Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol. CITA, HB, ITEC, JPLT, PRETEXT, SCT
2020 Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers. HPV, IMPT, IMRT
2020 Primitive Neuroectodermal Tumor as the Second Malignant Neoplasm in a Long-Term Survivor Child of Acute Lymphoblastic Leukemia: A Case Report. ALL, PNET
2020 Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents. CNS, CPS, NHL, OS
10  2019 Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer. AAs, BCI, GEO, HR, RT, RTS, STEPP
11  2019 Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations. PDAC
12  2019 Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy. ---
13  2019 Platinum exposure and cause-specific mortality among patients with testicular cancer. CI, HR, IHD, TC
14  2018 Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer. DCIS, SEER
15  2018 Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers. CSI, LMICs
16  2018 Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma. CI, CNS, CSI, MB, RT, SBNs, SNs
17  2018 Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea. EAR, PYR, SIR
18  2017 Impact of liver transplantation on the risk of second malignant tumors among hepatocellular carcinoma patients. HCC, SEER, SIRs
19  2017 Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma. DS-PBT, IMRT
20  2017 Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival. CSS, IRR, RT
21  2017 Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: Apopulation-based study. CI, non-CNS, SIR
22  2017 Second Malignant Neoplasms in Childhood Cancer Survivors Treated in a Tertiary Paediatric Oncology Centre. ---
23  2016 Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey. AML, CNS, MDS, OS, PMNs
24  2016 Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study. Rb, RR
25  2016 Controversies in the management of clinical stage I testicular seminoma. ACT, ART, AS, CSI, PFS
26  2016 Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin's Lymphoma Survivors. Gy, HL, IRB, RT
27  2016 Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. CVDs, GI, HF, HL, RR
28  2016 Neuroblastoma: A Tough Nut to Crack. ---
29  2016 Risk of second malignant neoplasms in women and girls with germ cell tumors. CI, GCTs
30  2016 Second malignancy risk among pediatric, adolescent, and young adult survivors of fusion-positive and fusion-negative sarcomas: Results from the SEER database, 1992 through 2012. aHR, SEER, SHR, SIRs
31  2016 Therapeutic radiation and the potential risk of second malignancies. ---
32  2015 Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis. NRSs, RCTs, RR
33  2015 Increased risk of second malignant neoplasms in adolescents and young adults with cancer. AER, AYA, CIs, SEER, SIR
34  2015 Mutational Analysis of Ionizing Radiation Induced Neoplasms. IR
35  2015 Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT). CI, EAR, IMRT, RT, SIRs
36  2015 Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood. HSCT
37  2015 Secondary malignant neoplasms in testicular cancer survivors. ---
38  2014 Local radiation dose and solid second malignant neoplasms after childhood cancer in Germany: a nested case-control study. GCCR, RT
39  2014 Methodological extensions of meta-analysis with excess relative risk estimates: application to risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy. ERR
40  2014 Multiple myeloma and other malignancies: a pilot study from the Houston VA. MM
41  2014 Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma. SEER, SIR
42  2013 Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma. NPC, OS
43  2012 Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults. CI, CMT, SIR
44  2012 Second malignancies after autologous hematopoietic cell transplantation in children. auto-HCT, CI, MDS
45  2012 Second malignant neoplasms: assessment and strategies for risk reduction. SEER
46  2011 Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis. NHL, RR
47  2011 Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhone-Alpes region (ARCERRA) in France. CI, SIR
48  2011 The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. ALL, AML, CI, MDS
49  2011 Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. ---
50  2010 Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma. HCC, IMRT, PBT
51  2010 Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. HL
52  2010 Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study. CCSS, CI, OR
53  2009 Early and late mortality after diagnosis of wilms tumor. RR, SMRs, WT
54  2009 Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. CCSS, SNs
55  2008 Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane. ALL, HR
56  2008 Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. NHL, RR, SIRs, SMRs
57  2008 Hodgkin lymphoma as second malignancy during continuing chemotherapy for childhood acute lymphoblastic leukemia. ALL, CT, HL
58  2008 Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study. CI, CNS, SIRs
59  2008 Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort. CI, ES, OS
60  2007 Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. ABVE-PC, AML, CIR, DRZ, HD, MDS, POG, SIR
61  2007 Mucoepidermoid carcinoma as a secondary malignancy in pediatric sarcoma. ES, OS
62  2007 Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. AERs, CVDs, SIRs, TC
63  2005 A mouse model for studying therapy-induced cancers. ---
64  2004 Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group. ALL, HD
65  2004 Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. SIR
66  2004 Mucoepidermoid carcinoma of the parotid gland as a second malignant neoplasm. ALL, MEC
67  2004 Philadelphia chromosome-positive acute lymphoblastic leukemia secondary to chemoradiotherapy for Ewing sarcoma. Report of two cases and concise review of the literature. ALL, AML, ES, MDS
68  2004 Second malignant neoplasms in childhood acute lymphoblastic leukemia: primitive neuroectodermal tumor of the chest wall with germline p53 mutation as a second malignant neoplasm. ALL, PNET
69  2003 Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. ---
70  2003 Second malignancies in pediatric patients: imaging findings and differential diagnosis. CNS
71  2003 Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. CNS, SIR
72  2003 TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms. HD
73  2000 Colorectal adenocarcinoma as a second malignant neoplasm following rhabdomyosarcoma of the urinary bladder: a case report. ---
74  2000 Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years. CY, Mel
75  2000 Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. CI, SIRs
76  2000 Synchronous wilms tumor and fibrolamellar hepatocellular carcinoma: report of a case. FHCC, WT
77  1997 Primitive neuroectodermal tumor of bone as a second malignant neoplasm in a child previously treated for acute lymphoblastic leukemia. ALL, PNET
78  1997 Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6. SIR
79  1996 Postirradiation sarcoma of the gynecologic tract. A report of 13 cases and a discussion of the risk of radiation-induced gynecologic malignancies. PIS, RT, UCLA
80  1995 Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group. CI, NWTS, SIR
81  1995 Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. ANLL, RMS
82  1992 Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. ALL, ANLL
83  1988 Second malignant neoplasms in survivors of Wilms' tumor: a report from the National Wilms' Tumor Study. CI
84  1987 Cancer in survivors of childhood soft tissue sarcoma and their relatives. ---
85  1982 Incidence of second malignant neoplasms in children: results of an international study. ---
86  1976 Decreased risk of radiation-associated second malignant neoplasms in actinomycin-D-treated patients. AMD